• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADAMTS1 通过调节 TGF-β 诱导非小细胞肺癌中的上皮-间充质转化途径。

ADAMTS1 induces epithelial-mesenchymal transition pathway in non-small cell lung cancer by regulating TGF-β.

机构信息

Department of Oncology, Ningbo Municipal Hospital of TCM, Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, China.

Department of Cardiovascular Division, Ningbo Municipal Hospital of TCM, Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, China.

出版信息

Aging (Albany NY). 2023 Mar 20;15(6):2097-2114. doi: 10.18632/aging.204594.

DOI:10.18632/aging.204594
PMID:36947712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10085599/
Abstract

Non-small cell lung cancer (NSCLC) accounts for approximately 80% of all lung cancers. Identifying key molecular targets related to the initiation, development, and metastasis of lung cancer is important for its diagnosis and target therapy. The ADAMTS families of multidomain extracellular protease enzymes have been reported to be involved in many physiological processes. In this study, we found that ADAMTS1 was highly expressed in NSCLC tissues, which promoted cell proliferation, migration, invasion, and epithelial to mesenchymal transition (EMT) of NSCLC cells. In the NSCLC tumor metastasis model involving nude mice, overexpression of ADAMTS1 promoted EMT and lung metastasis of tumor cells. Moreover, ADAMTS1 positively regulated TGF-β expression, and TGF-β was highly expressed in NSCLC tumor tissues. si-TGF-β or inhibition of TGF-β expression through the short peptide KTFR on ADAMTS1 protein could reverse the oncogenic effects of ADAMTS1 on lung cancer cells. Taken together, ADAMTS1 functioned as an oncogene in NSCLC cells by promoting TGF-β expression, indicating that ADAMTS1 has important regulatory roles in the progression of NSCLC.

摘要

非小细胞肺癌(NSCLC)约占所有肺癌的 80%。鉴定与肺癌的发生、发展和转移相关的关键分子靶标对于其诊断和靶向治疗非常重要。ADAMTS 家族的多种结构域细胞外蛋白酶已被报道参与许多生理过程。在本研究中,我们发现 ADAMTS1 在 NSCLC 组织中高表达,促进 NSCLC 细胞的增殖、迁移、侵袭和上皮间质转化(EMT)。在涉及裸鼠的 NSCLC 肿瘤转移模型中,ADAMTS1 的过表达促进了肿瘤细胞的 EMT 和肺转移。此外,ADAMTS1 正向调节 TGF-β 的表达,而 TGF-β 在 NSCLC 肿瘤组织中高表达。si-TGF-β 或通过 ADAMTS1 蛋白上的短肽 KTFR 抑制 TGF-β 的表达可以逆转 ADAMTS1 对肺癌细胞的致癌作用。总之,ADAMTS1 通过促进 TGF-β 的表达在 NSCLC 细胞中发挥癌基因作用,表明 ADAMTS1 在 NSCLC 的进展中具有重要的调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/b900d2130d16/aging-15-204594-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/ddf720dc1b36/aging-15-204594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/e3d288345ea0/aging-15-204594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/01b0589406a8/aging-15-204594-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/e294df99e7c4/aging-15-204594-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/7b01ad48e007/aging-15-204594-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/73da87c6cbc5/aging-15-204594-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/e2b1d9406f13/aging-15-204594-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/bff2c7d85672/aging-15-204594-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/b900d2130d16/aging-15-204594-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/ddf720dc1b36/aging-15-204594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/e3d288345ea0/aging-15-204594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/01b0589406a8/aging-15-204594-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/e294df99e7c4/aging-15-204594-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/7b01ad48e007/aging-15-204594-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/73da87c6cbc5/aging-15-204594-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/e2b1d9406f13/aging-15-204594-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/bff2c7d85672/aging-15-204594-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c214/10085599/b900d2130d16/aging-15-204594-g009.jpg

相似文献

1
ADAMTS1 induces epithelial-mesenchymal transition pathway in non-small cell lung cancer by regulating TGF-β.ADAMTS1 通过调节 TGF-β 诱导非小细胞肺癌中的上皮-间充质转化途径。
Aging (Albany NY). 2023 Mar 20;15(6):2097-2114. doi: 10.18632/aging.204594.
2
MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.微小 RNA-422a 通过 SULF2 介导的 TGF-β/SMAD 信号通路在非小细胞肺癌中发挥肿瘤抑制作用。
Cell Cycle. 2019 Aug;18(15):1727-1744. doi: 10.1080/15384101.2019.1632135. Epub 2019 Jun 28.
3
Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.长链非编码 RNA XIST 通过调控 miR-367/141-ZEB2 轴促进 TGF-β诱导的非小细胞肺癌上皮-间质转化。
Cancer Lett. 2018 Apr 1;418:185-195. doi: 10.1016/j.canlet.2018.01.036. Epub 2018 Jan 17.
4
MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.在非小细胞肺癌细胞中,miR-145和miR-203通过抑制SMAD3来抑制转化生长因子-β诱导的上皮-间质转化和侵袭。
Lung Cancer. 2016 Jul;97:87-94. doi: 10.1016/j.lungcan.2016.04.017. Epub 2016 Apr 27.
5
TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.TRIM66通过调节MMP9介导的TGF-β/SMAD途径加速非小细胞肺癌的恶性进展。
Cytokine. 2022 May;153:155831. doi: 10.1016/j.cyto.2022.155831. Epub 2022 Mar 14.
6
Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.SOX2对TIF1γ的抑制促进了非小细胞肺癌中转化生长因子-β诱导的上皮-间质转化。
Oncogene. 2016 Feb 18;35(7):867-77. doi: 10.1038/onc.2015.141. Epub 2015 May 11.
7
Forkhead box L2 is a target of miR-133b and plays an important role in the pathogenesis of non-small cell lung cancer.叉头框蛋白 L2 是 miR-133b 的靶标,在非小细胞肺癌的发病机制中发挥重要作用。
Cancer Med. 2023 Apr;12(8):9826-9842. doi: 10.1002/cam4.5746. Epub 2023 Feb 27.
8
Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma.转录因子PREP1通过调控非小细胞肺腺癌中的TGF-β-SMAD3信号通路诱导上皮-间质转化和转移。
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):E3775-84. doi: 10.1073/pnas.1407074111. Epub 2014 Aug 25.
9
MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer.肌细胞生成素(MYOCD)和 SMAD3/SMAD4 形成正反馈回路,驱动 TGF-β 诱导的非小细胞肺癌上皮-间充质转化。
Oncogene. 2020 Apr;39(14):2890-2904. doi: 10.1038/s41388-020-1189-4. Epub 2020 Feb 6.
10
MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.微小 RNA-92a 通过激活 PTEN/PI3K/AKT 信号通路促进非小细胞肺癌转移中的上皮-间充质转化。
Int J Oncol. 2017 Jul;51(1):235-244. doi: 10.3892/ijo.2017.3999. Epub 2017 May 16.

引用本文的文献

1
The GD3 ganglioside promotes cell growth, plasticity and chemotherapy resistance of human glioblastoma cancer stem cells.GD3神经节苷脂可促进人类胶质母细胞瘤癌症干细胞的细胞生长、可塑性及化疗抗性。
Cancer Cell Int. 2025 Jul 2;25(1):246. doi: 10.1186/s12935-025-03790-2.
2
The protease ADAMTS5 controls ovarian cancer cell invasion, downstream of Rab25.蛋白酶ADAMTS5在Rab25下游调控卵巢癌细胞的侵袭。
FEBS J. 2025 Sep;292(17):4491-4515. doi: 10.1111/febs.70080. Epub 2025 Mar 31.
3
p85β acts as a transcription cofactor and cooperates with BCLAF1 in the nucleus.

本文引用的文献

1
Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics.肿瘤微环境信号对上皮-间充质转化的调控及其在癌症治疗中的意义。
Semin Cancer Biol. 2023 Jan;88:46-66. doi: 10.1016/j.semcancer.2022.12.002. Epub 2022 Dec 13.
2
Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions.通过非小细胞肺癌中的组织分子梯度对细胞外基质进行建模以用于临床决策。
Front Oncol. 2022 Nov 14;12:1042766. doi: 10.3389/fonc.2022.1042766. eCollection 2022.
3
TRPV3 promotes the angiogenesis through HIF-1α-VEGF signaling pathway in A549 cells.
p85β作为一种转录辅因子,在细胞核中与BCLAF1协同作用。
Nat Commun. 2025 Feb 27;16(1):2042. doi: 10.1038/s41467-025-56532-3.
4
Gene function revealed at the moment of stochastic gene silencing.基因功能在随机基因沉默之时得以揭示。
Commun Biol. 2025 Jan 19;8(1):88. doi: 10.1038/s42003-025-07530-0.
5
Investigating the anti-cancer potential of sulfatase 1 and its underlying mechanism in non-small cell lung cancer.研究硫酸酯酶1在非小细胞肺癌中的抗癌潜力及其潜在机制。
Cytojournal. 2024 Nov 23;21:52. doi: 10.25259/Cytojournal_71_2024. eCollection 2024.
6
ADAMTS16 drives epithelial-mesenchymal transition and metastasis through a feedback loop upon TGF-β1 activation in lung adenocarcinoma.ADAMTS16 通过 TGF-β1 激活后的反馈环驱动肺腺癌中的上皮-间质转化和转移。
Cell Death Dis. 2024 Nov 17;15(11):837. doi: 10.1038/s41419-024-07226-z.
7
Associations of SEMA7A, SEMA4D, ADAMTS10, and ADAM8 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, Microsatellite Instability Status, and Cytokine Expression in Colorectal Cancer Tissue.SEMA7A、SEMA4D、ADAMTS10和ADAM8与结直肠癌组织中KRAS、NRAS、BRAF、PIK3CA和AKT基因突变、微卫星不稳定性状态及细胞因子表达的相关性
Curr Issues Mol Biol. 2024 Sep 15;46(9):10218-10248. doi: 10.3390/cimb46090609.
8
ADAMTS Proteases: Their Multifaceted Role in the Regulation of Cancer Metastasis.ADAMTS蛋白酶:它们在癌症转移调控中的多方面作用
Dis Res. 2024;4(1):40-52. doi: 10.54457/DR.202401004.
9
MicroRNAs and proteolytic cleavage of receptors in cancers: A comprehensive review of regulatory interactions and therapeutic implications.癌症中微小RNA与受体的蛋白水解切割:调控相互作用及治疗意义的全面综述
Heliyon. 2024 Mar 20;10(7):e28167. doi: 10.1016/j.heliyon.2024.e28167. eCollection 2024 Apr 15.
10
Cyclic increase in the ADAMTS1-L1CAM-EGFR axis promotes the EMT and cervical lymph node metastasis of oral squamous cell carcinoma.ADAMTS1-L1CAM-EGFR 轴的循环增加促进口腔鳞状细胞癌的 EMT 和颈部淋巴结转移。
Cell Death Dis. 2024 Jan 23;15(1):82. doi: 10.1038/s41419-024-06452-9.
TRPV3 通过 HIF-1α-VEGF 信号通路促进 A549 细胞的血管生成。
Acta Histochem. 2022 Dec;124(8):151955. doi: 10.1016/j.acthis.2022.151955. Epub 2022 Oct 28.
4
Management of Lung Cancer Presenting with Solitary Bone Metastasis.肺癌伴孤立性骨转移的治疗。
Medicina (Kaunas). 2022 Oct 16;58(10):1463. doi: 10.3390/medicina58101463.
5
Non-small cell lung cancer in China.中国的非小细胞肺癌。
Cancer Commun (Lond). 2022 Oct;42(10):937-970. doi: 10.1002/cac2.12359. Epub 2022 Sep 8.
6
Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition.模拟非小细胞肺癌细胞系中的再氧合作用并显示上皮-间充质转化。
J Cancer Res Clin Oncol. 2022 Dec;148(12):3501-3510. doi: 10.1007/s00432-022-04242-4. Epub 2022 Aug 6.
7
The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy.ADAMTS8在无可靶向治疗的肺腺癌中的治疗潜力
J Pers Med. 2022 May 30;12(6):902. doi: 10.3390/jpm12060902.
8
A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition.一种针对碱性成纤维细胞生长因子的单克隆抗体通过抑制上皮-间充质转化来减弱肺癌的顺铂耐药性。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221105134. doi: 10.1177/03946320221105134.
9
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.中国和美国 2022 年癌症统计数据:概况、趋势和决定因素。
Chin Med J (Engl). 2022 Feb 9;135(5):584-590. doi: 10.1097/CM9.0000000000002108.
10
ADAMTS-1 inhibits angiogenesis via the PI3K/Akt-eNOS-VEGF pathway in lung cancer cells.ADAMTS-1通过PI3K/Akt-eNOS-VEGF途径抑制肺癌细胞的血管生成。
Transl Cancer Res. 2019 Dec;8(8):2725-2735. doi: 10.21037/tcr.2019.10.34.